CAARUD: client profiles and practices in 2008

 

CAARUD: client profiles and practices in 2008

Tendances n° 74, OFDT, 9 p.
December 2010

The status of CAARUD (Support Centres for the Reduction of Drug-related Harms) has been accessible since 2006 to structures (e.g., "drop-in", needle exchange programmes, street teams and mediation teams) that carry out drug-related harm reduction missions.
French CAARUDs mainly admit drug users who, although they can be followed up by healthcare system services (whether or not specialised in addictology), tend to have, on average, more uncontrolled addiction than users in general and live in more unstable social situations.
In order to acquire monitoring indicators for the characteristics of treated drug users and help improve the responses of professionals and authorities to the changing needs of this population, a biennial national survey of treated drug users was announced by the National Health Directorate (DGS). The survey is called "ENa-CAARUD".
This issue of Tendances presents the main results of the second edition of this survey, which was conducted in 2008.

Authors : Agnès Cadet-Taïrou, Anaëlle Coquelin, Abdalla Toufik

Download the PDF file (490 Ko)

Drugs in Europe

2016 EMCDDA European Drug Report

- Drug facts, figures and analyses: across Europe and by country
- Latest trends and legal, political and social responses
- Selected issues: Vulnerable groups of young people; National drug-related research in Europe; Towards a better understanding of drug-related public expenditure in Europe

Country situation summaries

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) website has a concise overview for each EU Member State on their national drug situation, as well as legal texts in their original formats, an indispensable tool for monitoring and analysing legislative developments in the Member States.

The European Union and the drug phenomenon

The European Union & the drug phenomenon : Frequently asked questions , joint publication between the EMCDDA and the European Commission, october 2010, 12 p.